We are live on ! Find out more
BAM

Belpointe Asset Management Portfolio holdings

AUM $3.06B
1-Year Est. Return 23.82%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+23.82%
3 Year Est. Return
+80.11%
5 Year Est. Return
+96.42%
10 Year Est. Return
AUM
$1.65B
AUM Growth
+$175M
Cap. Flow
+$87.3M
Cap. Flow %
5.27%
Top 10 Hldgs %
20.31%
Holding
3,687
New
2,520
Increased
502
Reduced
607
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 10.93%
2 Financials 8.15%
3 Healthcare 7.36%
4 Consumer Discretionary 4.69%
5 Industrials 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCM
2076
DELISTED
Abcam PLC
ABCM
$23.2K ﹤0.01%
+1,493
New +$23.3K
PANL icon
2077
Pangaea Logistics
PANL
$483M
$23.2K ﹤0.01%
+4,500
New +$22.2K
TU icon
2078
Telus
TU
$15.4B
$23.2K ﹤0.01%
+1,200
New +$24.8K
UNF icon
2079
Unifirst Corp
UNF
$5.25B
$23.2K ﹤0.01%
+120
New +$21.9K
LSTR icon
2080
Landstar System
LSTR
$6.2B
$23.1K ﹤0.01%
+142
New +$22.8K
PFEB icon
2081
Innovator US Equity Power Buffer ETF February
PFEB
$927M
$23K ﹤0.01%
+811
New +$22.6K
MUR icon
2082
Murphy Oil
MUR
$4.9B
$23K ﹤0.01%
+535
New +$24.1K
IONS icon
2083
Ionis Pharmaceuticals
IONS
$9.19B
$23K ﹤0.01%
+608
New +$25.6K
MMSI icon
2084
Merit Medical Systems
MMSI
$5.31B
$23K ﹤0.01%
+325
New +$21.7K
KN icon
2085
Knowles
KN
$3.34B
$22.9K ﹤0.01%
+1,395
New +$20.3K
WATT icon
2086
Energous
WATT
$101M
$22.8K ﹤0.01%
+46
New +$27.7K
VRSN icon
2087
VeriSign
VRSN
$26.5B
$22.8K ﹤0.01%
+111
New +$21.3K
BCI icon
2088
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.97B
$22.8K ﹤0.01%
+1,033
New +$26.7K
FXI icon
2089
iShares China Large-Cap ETF
FXI
$4.31B
$22.8K ﹤0.01%
+804
New +$20.8K
IMO icon
2090
Imperial Oil
IMO
$60.7B
$22.7K ﹤0.01%
+466
New +$24K
TMDX icon
2091
Transmedics
TMDX
$2.78B
$22.7K ﹤0.01%
+368
New +$19.6K
SCHE icon
2092
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$22.7K ﹤0.01%
+959
New +$22.3K
YEXT icon
2093
Yext
YEXT
$569M
$22.7K ﹤0.01%
+3,473
New +$18.9K
VC icon
2094
Visteon
VC
$2.81B
$22.6K ﹤0.01%
+173
New +$23K
OR icon
2095
OR Royalties Inc
OR
$6.1B
$22.6K ﹤0.01%
+1,875
New +$21.7K
EWBC icon
2096
East-West Bancorp
EWBC
$18.1B
$22.6K ﹤0.01%
+343
New +$23.5K
FYBR
2097
DELISTED
Frontier Communications
FYBR
$22.6K ﹤0.01%
+885
New +$21.3K
CSM icon
2098
ProShares Large Cap Core Plus
CSM
$535M
$22.5K ﹤0.01%
+502
New +$22.9K
RBA icon
2099
RB Global
RBA
$17.6B
$22.5K ﹤0.01%
+389
New +$22.6K
FAF icon
2100
First American
FAF
$7.63B
$22.5K ﹤0.01%
+430
New +$21.8K

Similar funds

Belpointe Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Belpointe Asset Management held 3,687 positions worth $1.65B, up 12% from $1.48B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Belpointe Asset Management deployed $87.3M of net new capital in Q4 2022, opening 2,520 new positions and adding to 502 existing holdings. Its largest new stake was Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033: 50,066 shares worth $7.36M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $11.1M trimmed.

  • Belpointe Asset Management's largest Q4 2022 buy was Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033: 50,066 shares worth $7.36M.
  • Belpointe Asset Management added most to Schwab US Broad Market ETF in Q4 2022, an estimated $17.8M increase.
  • Belpointe Asset Management's biggest Q4 2022 reduction was iShares Short Maturity Bond ETF, cutting an estimated $11.1M.
  • Belpointe Asset Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.12M.
  • Belpointe Asset Management's ten largest holdings make up 20% of its $1.65B portfolio in Q4 2022.
  • Belpointe Asset Management opened 2,520 new positions and closed 10 in Q4 2022.
  • Belpointe Asset Management's portfolio value rose 12% quarter-over-quarter to $1.65B.

Based on Belpointe Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.